<SEC-DOCUMENT>0000784199-16-000241.txt : 20160414
<SEC-HEADER>0000784199-16-000241.hdr.sgml : 20160414
<ACCEPTANCE-DATETIME>20160414082501
ACCESSION NUMBER:		0000784199-16-000241
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20160414
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160414
DATE AS OF CHANGE:		20160414

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYOLIFE INC
		CENTRAL INDEX KEY:			0000784199
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				592417093
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13165
		FILM NUMBER:		161570486

	BUSINESS ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
		BUSINESS PHONE:		7704193355

	MAIL ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c199-20160414x8k.htm
<DESCRIPTION>8-K
<TEXT>
<!--HTML document created with Certent Powered by Crossfire 6.0.1.12-->
<!--Created on: 4/14/2016 8:23:20 AM-->
<html>
	<head>
		<title>
			8K GBI option  4-14-16
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;">
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:115%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<a name="_GoBack"></a><font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 1pt">
						<font style="display: inline;font-family:Times New Roman;font-size:1pt;">&#xFEFF;</font><a name="_DV_M0"></a><font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 14pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">UNITED STATES</font><font style="display: inline;font-family:Times New Roman;font-size:14pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 14pt">
			<a name="_DV_M1"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">SECURITIES AND EXCHANGE COMMISSION</font><br /><font style="display: inline;font-family:Times New Roman;font-size:14pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:13pt;">Washington, D.C. &nbsp;20549</font><br /><font style="display: inline;font-family:Times New Roman;font-size:14pt;"></font><font style="display: inline;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:14pt;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:126.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:12pt 0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 14pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">FORM 8-K</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M2"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">CURRENT REPORT</font><br /><font style="display: inline;font-family:Times New Roman;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">PURSUANT TO SECTION 13 OR 15(d) OF THE</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M3"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">SECURITIES EXCHANGE ACT OF 1934</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 10pt">
			<a name="_DV_M4"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">Date of Report (Date of earliest event reported):&nbsp; </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">April 1</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">4</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">,</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;"> 2016</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M5"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">_______________________</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 18pt">
			<a name="_DV_M6"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:18pt;">CRYOLIFE, INC.</font><font style="display: inline;font-family:Times New Roman;font-size:18pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 10pt">
			<a name="_DV_M7"></a><font style="display: inline;font-family:Times New Roman;font-size:10pt;">(Exact name of registrant as specified in its charter)</font><br /><font style="display: inline;font-family:Times New Roman;font-size:10pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">_________________________</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 1pt">
						<font style="display: inline;font-family:Times New Roman;font-size:1pt;">&#xFEFF;</font><a name="_DV_M8"></a><font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;overflow: hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;overflow: hidden;font-size:0pt;">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;">Florida</font><font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;">1-13165</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 11pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;">59-2417093</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-size:9pt;">(State or Other Jurisdiction</font><br /><font style="display: inline;font-family:Times New Roman;font-size:9pt;">of Incorporation)</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-size:9pt;">(Commission File Number)</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-size:9pt;">(IRS Employer</font></p>
					<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
						<font style="display: inline;font-family:Times New Roman;font-size:9pt;">Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">1655 Roberts Boulevard, N.W., </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Kennesaw, </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Georgia &nbsp;30144</font><br /><font style="display: inline;font-family:Times New Roman;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;font-size:9pt;">(Address of principal executive office) (zip code)</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 11pt">
			<a name="_DV_M9"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;">Registrant's telephone number, including area code: (770) 419-3355</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
			<a name="_DV_M10"></a><font style="display: inline;font-family:Times New Roman;font-size:9pt;">_____________________________________________________________ </font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 9pt">
			<a name="_DV_M11"></a><font style="display: inline;font-family:Times New Roman;font-size:9pt;">(Former name or former address, if changed since last report)</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:center;font-family:Calibri;font-size: 10pt">
			<a name="_DV_M12"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:10pt;">_________________________</font><font style="display: inline;font-family:Times New Roman;font-size:10pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M13"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </font>
		</p>
		<p style="margin:0pt;line-height:normal;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:MS Mincho;font-size:12pt;">&#x2610;</font><a name="_DV_M14"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </font>
		</p>
		<p style="margin:0pt 0pt 0pt 90pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M15"></a><font style="display: inline;font-family:MS Mincho;font-size:12pt;">&#x2610;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </font>
		</p>
		<p style="margin:0pt 0pt 0pt 90pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M16"></a><font style="display: inline;font-family:MS Mincho;font-size:12pt;">&#x2610;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </font>
		</p>
		<p style="margin:0pt 0pt 0pt 90pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:MS Mincho;font-size:12pt;">&#x2610;</font><a name="_DV_M17"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;;font-size: 12pt"><font style="display: inline;font-family:Times New Roman;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt 0pt 0pt 72pt;line-height:normal;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Times New Roman;font-size: 12pt">
			<a name="S110762357"></a><font style="display: inline;font-weight:bold;">Item 8.01 Other Events.</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 1.5pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">On </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">April</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> &nbsp;1</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">4</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, 2016, </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">CryoLife, Inc.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, a </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Florida</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> corporation (the &#x201C;Company&#x201D;), issued a</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> press release </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">announcing</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">the exercise of its purchase option under that certain Exclusive Supply and Distribution Agreement with </font><a name="T0"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Genesee Biomedical</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, Inc</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">.&nbsp; </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">A copy of the</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> press release</font><a name="T1"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:right;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Item 9.01 </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Financial Statements and Exhibits.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">(d)</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;;font-size: 12pt;font-family:Calibri;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">Exhibits</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;"> &nbsp; </font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:117.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Exhibit Number</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:117.90pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">99.1*</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt solid #000000 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Press release dated </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">April 1</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">4</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, 2016</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">*This exhibit is furnished, not filed. </font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M30"></a><a name="_DV_M38"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 216pt;line-height:100%;text-indent: -108pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;font-family:Calibri;line-height:115%;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt 0pt 10pt;font-family:Calibri;line-height:115%;;font-size: 12pt"><font style="display: inline;font-family:Times New Roman;font-size:12pt;"></font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:right;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:right;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">SIGNATURES</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M39"></a><br /><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </font>
		</p>
		<p style="margin:0pt;line-height:100%;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp; &nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:115%;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;height:1.00pt">
					<p style="margin:0pt;font-family:Calibri;line-height:115%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">CRYOLIFE, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Date:&nbsp; </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">April 14,</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> 2016</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">By: </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;text-decoration:underline;">/s/ D. Ashley Lee </font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Name:&nbsp;&nbsp;&nbsp;D. Ashley Lee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;">&nbsp;</font></p>
				</td>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 7.8pt 0pt 7.8pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Title:&nbsp;&nbsp;&nbsp;Exe</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">cutive Vice President, Chief </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Operating Officer and Chief Financial Officer&nbsp; </font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 10pt;font-family:Calibri;line-height:115%;font-size: 11pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>c199-20160414xex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Certent Powered by Crossfire 6.0.1.12-->
<!--Created on: 4/14/2016 8:23:25 AM-->
<html>
	<head>
		<title>
			8K GBI option exhibit 991  4-14-16
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 10pt">

			<font style="display: inline;font-size:10pt;">Exhibit 99.1</font>

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<a name="_GoBack"></a><font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;text-align:left;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M0"></a><font style="display: inline;font-style:italic;font-size:12pt;">FOR IMMEDIATE RELEASE </font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">Contacts:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;color:#000000;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:261.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 12pt">
						<font style="display: inline;color:#000000;">&#xFEFF;</font></p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden">
						<font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;"></font></p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 12pt">
						<font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phone: 770-419-3355</font></p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:210.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:261.90pt;height:71.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;color:#000000;">CryoLife </font><font style="display: inline;font-weight:bold;color:#000000;"></font></p>
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">D. Ashley Lee</font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;"></font></p>
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">Executive Vice President, Chief Financial Officer </font></p>
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">and Chief Operating Officer</font><font style="display: inline;color:#000000;"></font></p>
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">Phone: 770-419-3355</font></p>
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;color:#FFFFFF;">phone</font></p>
				</td>
				<td valign="top" style="width:210.90pt;height:71.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;color:#000000;">The Ruth Group</font></p>
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">Nick Laudico / Zack Kubow</font></p>
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;">646-536-7030 / 7020</font></p>
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;text-decoration:underline;">nlaudico@theruthgroup.com</font></p>
					<p style="margin:0pt 0pt 0pt 17.1pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;color:#000000;text-decoration:underline;">zkubow@theruthgroup.com</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 11pt">
			<font style="display: inline;font-size:11pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<a name="OLE_LINK1"></a><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;">CryoLife </font><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;">Exercises</font><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;"> Right to Acquire </font><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;">PhotoFix</font><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;">&#x2122;</font><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;"> Bovine Pericardium Patch</font><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;"> from Genes</font><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;">e</font><font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;">e BioMedical</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<font style="font-family:Verdana;font-weight:bold;color:#000000;font-size:9pt;display: inline;font-family:Times New Roman;text-transform:none;font-size:14pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M6"></a><font style="display: inline;font-weight:bold;color:#000000;">ATLANTA, GA&#x2026;(</font><font style="display: inline;font-weight:bold;color:#000000;">April </font><font style="display: inline;font-weight:bold;color:#000000;">14</font><font style="display: inline;font-weight:bold;color:#000000;">, 201</font><font style="display: inline;font-weight:bold;color:#000000;">6</font><font style="display: inline;font-weight:bold;color:#000000;">)&#x2026;CryoLife, Inc. (NYSE: CRY), </font><font style="display: inline;color:#000000;">a leading </font><font style="display: inline;color:#000000;">medical device and </font><font style="display: inline;color:#000000;">tissue processing </font><font style="display: inline;color:#000000;">c</font><font style="display: inline;color:#000000;">ompany focused on cardiac surgery</font><font style="display: inline;color:#000000;">, &nbsp;</font><font style="display: inline;">announced today </font><font style="display: inline;">that it </font><font style="display: inline;">has </font><font style="display: inline;">exercised</font><font style="display: inline;"> its right to acquire </font><font style="display: inline;">the </font><font style="display: inline;">PhotoFix</font><font style="display: inline;">&#x2122; bovine pericardium patch (&#x201C;PhotoFix&#x201D;)</font><font style="display: inline;"> from Genesee BioMedical, Inc.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">for $2.3 million in cash</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">CryoLife acquired the distribution rights and purchase option for PhotoFix in </font><font style="display: inline;">August 2014.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">J. Patrick Mackin, Chairman, President, and Chief Executiv</font><font style="display: inline;">e Officer of CryoLife, said, &#x201C;</font><font style="display: inline;">PhotoFix </font><font style="display: inline;">is</font><font style="display: inline;"> a highly </font><font style="display: inline;">differentiated </font><font style="display: inline;">product </font><font style="display: inline;">that complements </font><font style="display: inline;">our expanding</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">portfolio of</font><font style="display: inline;"> cardiac </font><font style="display: inline;">surgery</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">products</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">We achieved $1.4 million in PhotoFix sales in 2015 and have</font><font style="display: inline;"> a </font><font style="display: inline;">significa</font><font style="display: inline;">n</font><font style="display: inline;">t &nbsp;</font><font style="display: inline;">opportunity </font><font style="display: inline;">to continue driving adoption in the market,</font><font style="display: inline;"> particularly </font><font style="display: inline;">with</font><font style="display: inline;"> our </font><font style="display: inline;">expanded </font><font style="display: inline;">cardiac surgery sales force</font><font style="display: inline;"> that doubled </font><font style="display: inline;">in number </font><font style="display: inline;">following</font><font style="display: inline;"> the acquisition of On-</font><font style="display: inline;">X earlier this year</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">We believe Phot</font><font style="display: inline;">o</font><font style="display: inline;">Fix&#x2019;s photo-oxidation process</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">is unique </font><font style="display: inline;">and </font><font style="display: inline;">provides </font><font style="display: inline;">clinical advantages </font><font style="display: inline;">that </font><font style="display: inline;">will support its </font><font style="display: inline;">sales </font><font style="display: inline;">growth</font><font style="display: inline;"> and </font><font style="display: inline;">ultimately its </font><font style="display: inline;">adoption </font><font style="display: inline;">as </font><font style="display: inline;">a &nbsp;</font><font style="display: inline;">leading</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">biological patch</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">in the $30 million market for cardiac surgery</font><font style="display: inline;">.&#x201D;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">Under </font><font style="display: inline;">the </font><font style="display: inline;">terms of the agreement, </font><font style="display: inline;">CryoLife has </font><font style="display: inline;">exercised</font><font style="display: inline;"> its option to </font><font style="display: inline;">acquire </font><font style="display: inline;">all rights to the </font><font style="display: inline;">PhotoFix </font><font style="display: inline;">bovine pericardial patch </font><font style="display: inline;">for $2.</font><font style="display: inline;">3</font><font style="display: inline;"> million</font><font style="display: inline;"> in cash</font><font style="display: inline;">. &nbsp;</font><font style="display: inline;">This includes approximately $0.6 million that CryoLife </font><font style="display: inline;">previously </font><font style="display: inline;">provided to Genesee as an advance under the distribution agreement</font><font style="display: inline;">.&nbsp; </font><font style="display: inline;">Genes</font><font style="display: inline;">e</font><font style="display: inline;">e &nbsp;</font><font style="display: inline;">has agreed to </font><font style="display: inline;">continue to </font><font style="display: inline;">supply </font><font style="display: inline;">PhotoFix </font><font style="display: inline;">to </font><font style="display: inline;">CryoLife </font><font style="display: inline;">until </font><font style="display: inline;">CryoLife </font><font style="display: inline;">establishes </font><font style="display: inline;">manufact</font><font style="display: inline;">uring </font><font style="display: inline;">capabilities at its </font><font style="display: inline;">headquarters</font><font style="display: inline;">&nbsp;</font><font style="display: inline;">in</font><font style="display: inline;"> suburban</font><font style="display: inline;"> Atlanta, GA</font><font style="display: inline;">. CryoLife anticipates it will </font><font style="display: inline;">be </font><font style="display: inline;">manufacturing PhotoFix</font><font style="display: inline;"> by </font><font style="display: inline;">mid 2017</font><font style="display: inline;">.</font><font style="display: inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-weight:bold;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;font-size:12pt;">About CryoLife</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures.&nbsp;&nbsp;CryoLife markets and sells products in more than 80 countries worldwide.&nbsp;&nbsp;For additional information about CryoLife, visit our website, </font><font style="display: inline;color:#0000FF;">www.cryolife.com</font><font style="display: inline;color:#000000;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-style:italic;color:#000000;">Statements made in this press release that look forward in time or that express management's beliefs, expectations, or hopes are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.&nbsp; Such forward-looking statements reflect the views of management at the time such statements are made.&nbsp; These statements include those </font><font style="display: inline;font-style:italic;color:#000000;">regarding</font><font style="display: inline;font-style:italic;color:#000000;"> the</font><font style="display: inline;font-style:italic;color:#000000;"> highly differentiated nature of the </font><font style="display: inline;font-style:italic;">PhotoFix product, the complementary nature of the PhotoFix product to CryoLife&#x2019;s existing and potential portfolio of cardiac surgery products, </font><font style="display: inline;font-style:italic;">the expanding nature of our cardiac surgery </font><font style="display: inline;font-style:italic;">portfolio</font><font style="display: inline;font-style:italic;">, &nbsp;</font><font style="display: inline;font-style:italic;">our significant opportunity to continue driving adoption of </font><font style="display: inline;font-style:italic;">PhotoFix</font><font style="display: inline;font-style:italic;"> in the market, with or with out our expanded cardiac surgery sales force following our acquisition of On-X, and our belief that&nbsp;&nbsp;PhotoFix&#x2019;s photo-oxidation process is unique and has clinical advantages, and that both of these differentiators will support growth in sales and adoption as a leading biological patch&nbsp;&nbsp;in the $30 million market for cardiac surgery.&#x201D; </font><font style="display: inline;font-style:italic;color:#000000;"> These forward-looking statements are subject to a number of ri</font><font style="display: inline;font-style:italic;color:#000000;">sks, uncertainties, estimates, and assumptions that may cause actual results to differ materially from current expectations</font><font style="display: inline;font-style:italic;color:#000000;">.</font><font style="display: inline;font-style:italic;color:#000000;">&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">These risks and uncertainties include</font><font style="display: inline;font-style:italic;color:#000000;"> that the PhotoFix product </font><font style="display: inline;font-style:italic;color:#000000;">ceases to be</font><font style="display: inline;font-style:italic;color:#000000;">,</font><font style="display: inline;font-style:italic;color:#000000;">&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">highly differentiated, or clinically advantageous to competitor&#x2019;</font><font style="display: inline;font-style:italic;color:#000000;">&nbsp;</font><font style="display: inline;font-style:italic;color:#000000;">products or complementary to our existing or potential cardiac surgery product portfolio, that the significant opportunity to continuing driving sales and adoption of PhotoFix in the market as a leading biological patch, will not materialize or may diminish due to factors beyond our control, or that we may not realize the expected benefits from the exercise of our option to purchase the PhotoFix product line.</font><font style="display: inline;font-style:italic;color:#000000;"> &nbsp;These risks and uncertainties include the risk factors detailed in our Securities and Exchange Commission filings, including our Form 10-K for the year ended&nbsp;December 31, 201</font><font style="display: inline;font-style:italic;color:#000000;">5</font><font style="display: inline;font-style:italic;color:#000000;">&nbsp;and our subsequent filings with the SEC. CryoLife does not undertake to update its forward-looking statements.</font><font style="display: inline;font-style:italic;color:#000000;">&nbsp;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
